收费全文 | 1010篇 |
免费 | 77篇 |
国内免费 | 7篇 |
耳鼻咽喉 | 7篇 |
儿科学 | 46篇 |
妇产科学 | 9篇 |
基础医学 | 98篇 |
口腔科学 | 75篇 |
临床医学 | 108篇 |
内科学 | 172篇 |
皮肤病学 | 9篇 |
神经病学 | 39篇 |
特种医学 | 199篇 |
外科学 | 95篇 |
综合类 | 74篇 |
预防医学 | 58篇 |
眼科学 | 4篇 |
药学 | 45篇 |
中国医学 | 24篇 |
肿瘤学 | 32篇 |
2024年 | 2篇 |
2022年 | 7篇 |
2021年 | 11篇 |
2020年 | 7篇 |
2019年 | 7篇 |
2018年 | 17篇 |
2017年 | 20篇 |
2016年 | 18篇 |
2015年 | 18篇 |
2014年 | 34篇 |
2013年 | 61篇 |
2012年 | 62篇 |
2011年 | 52篇 |
2010年 | 49篇 |
2009年 | 46篇 |
2008年 | 51篇 |
2007年 | 70篇 |
2006年 | 28篇 |
2005年 | 33篇 |
2004年 | 22篇 |
2003年 | 13篇 |
2002年 | 8篇 |
2001年 | 17篇 |
2000年 | 8篇 |
1999年 | 16篇 |
1998年 | 56篇 |
1997年 | 51篇 |
1996年 | 39篇 |
1995年 | 23篇 |
1994年 | 26篇 |
1993年 | 23篇 |
1992年 | 6篇 |
1991年 | 7篇 |
1990年 | 6篇 |
1989年 | 18篇 |
1988年 | 24篇 |
1987年 | 21篇 |
1986年 | 13篇 |
1985年 | 22篇 |
1984年 | 10篇 |
1983年 | 10篇 |
1982年 | 9篇 |
1981年 | 8篇 |
1980年 | 10篇 |
1979年 | 2篇 |
1978年 | 6篇 |
1977年 | 7篇 |
1976年 | 10篇 |
1975年 | 7篇 |
1954年 | 1篇 |
In this study, periodontal ligament fibroblasts, ERM, alveolar bone cells and gingival fibroblasts were obtained from porcine periodontal ligament, alveolar bone and gingiva. This study investigated, in vitro, the effect of EMD at three concentrations on proliferation, cell attachment and expression of mRNA for two mineralised tissue-related proteins (osteopontin and bone sialoprotein).
As for other periodontal cells, the ERM proliferative response was enhanced by EMD. Attachment assays revealed a highly significant increase for ERM and gingival fibroblasts after EMD treatment at all concentrations. This study has also shown that EMD stimulated expression of osteopontin mRNA by ERM and alveolar bone cells.
The results from this study provide evidence that EMD enhanced cellular events related with proliferation, attachment and osteopontin mRNA expression by porcine periodontal cells, in a manner consistent with its role in periodontal regenerative therapy. 相似文献
DESIGN: Patient-specific questions received by the drug information service were reviewed and evaluated. A panel determined whether or not appropriate drug therapy would have been employed if the DIS had not been consulted. Potential outcomes of drug information requests were classified using a decision-tree model. A severity rating with potential cost avoidance was then attached to each applicable request to predict PCS of the DIS.
RESULTS: Seventy-seven of the 570 drug information responses in the six-week study period had assessable PCS to the institution. During the study interval, PCS were estimated to be $196,000. Projected to one year, PCS reached $1.7 million. Of the savings noted, most were in the categories of increased monitoring and additional treatment. Annual PCS using a sensitivity analysis ranged from $423,601 to $1,922,560 per year.
CONCLUSIONS: This model demonstrates that the DIS at our institution does provide substantial cost avoidance. This model may be modified to evaluate PCS in other areas of pharmacy practice. 相似文献